Successful azacitidine based treatment of therapy related myelodysplastic syndrome with normal karyotype occurred after acute myeloid leukemia

被引：0
|
作者：
Saltarelli, F. [1 ]
Tatarelli, C. [1 ]
Spiriti, M. A. Aloe [1 ]
Naso, V. [1 ]
Bianchi, M. P. [1 ]
Bianchi, M. P. [1 ]
Conte, E. [1 ]
Proia, S. [1 ]
Ferrari, A. [1 ]
机构：
[1] Univ Roma La Sapienza, S Andrea Hosp, Hematol, I-00185 Rome, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70241-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-194
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [41] Maintenance Azacitidine after Hematopoietic Stem Cell Transplantation for Relapse Prevention in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Americo, Andre Dias
    Kerbauy, Mariana Nassif
    da Silva, Cinthya Correa
    Chapchap, Eduardo Cerello
    Teixeira, Larissa
    de Souza dos Santos, Fabio Pirse
    Feitosa Ribeiro, Andreza Alice
    Hamerschlack, Nelson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S206 - S206
  • [42] Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study
    Pragati G. Advani
    Sara J. Schonfeld
    Rochelle E. Curtis
    Graça M. Dores
    Martha S. Linet
    Byron S. Sigel
    Clara J. K. Lam
    Margaret A. Tucker
    Stephen J. Chanock
    Lindsay M. Morton
    Leukemia, 2019, 33 : 2947 - 2978
  • [43] NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype
    Zhang, Yue
    Zhang, Meirong
    Yang, Lin
    Xiao, Zhijian
    LEUKEMIA RESEARCH, 2007, 31 (01) : 109 - 111
  • [44] Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia
    Vinod Pullarkat
    Keith W. Pratz
    Hartmut Döhner
    Christian Recher
    Michael J. Thirman
    Courtney D. DiNardo
    Pierre Fenaux
    Andre C. Schuh
    Andrew H. Wei
    Arnaud Pigneux
    Jun-Ho Jang
    Gunnar Juliusson
    Yasushi Miyazaki
    Dominik Selleslag
    Martha L. Arellano
    Chenglong Liu
    Jean A. Ridgeway
    Jalaja Potluri
    Jovita Schuler
    Marina Konopleva
    Blood Cancer Journal, 15 (1)
  • [45] Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication
    Fordham, Sarah E.
    Marr, Helen
    Allan, James M.
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 447 - 448
  • [46] Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
    Edlin, R.
    Connock, M.
    Tubeuf, S.
    Round, J.
    Fry-Smith, A.
    Hyde, C.
    Greenheld, W.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 69 - 74
  • [47] Successful ixazomib treatment for relapsed and refractory acute myeloid leukemia transformed from myelodysplastic syndrome
    Oka, Satoko
    Ono, Kazuo
    CLINICAL CASE REPORTS, 2021, 9 (06):
  • [48] IMPACT OF AZACITIDINE TREATMENT ON INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROMES AND MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROMES
    Villegas, C.
    Ortiz, S.
    Javier, K.
    Costa, S.
    Ivars, D.
    Collado, R.
    Lopez, M.
    Irene, L.
    Roig, M.
    Sanchez, M.
    Perez, P.
    Orero, M.
    HAEMATOLOGICA, 2016, 101 : 483 - 483
  • [49] Therapy-related myelodysplastic syndrome (t-MDS) following treatment of acute myeloid leukemia (AML)
    Arana-Yi, C.
    Block, A. W.
    Sait, S. N.
    Ford, L. A.
    Barcos, M.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia
    AW Bseiso
    H Kantarjian
    E Estey
    Leukemia, 1997, 11 : 168 - 169
12345